Funding
Researcher : Maite Alvarez Rodriguez
9 funding - 2,193,177€
2022
2021
-
Integrating 4-1BB (CD137) agonists, interleukin-12, interleukin-18 and TGFb; antagonists in synergistic combined cancer
euro 459,800.00
-
ACTILNET. INTERLEUKIN-8 AND NEUTROPHIL EXTRACELULAR TRAPS AS ACTIONABLE HURDLES FOR CANCER IMMUNOTHERAPY
euro 498,850.00
-
Ensayo clínico fase I/II: nuevo enfoque terapéutico para el tratamiento de tumores sólidos con metástasis hepática
euro 270,482.00
-
Desarrolo preclínico y translacional de una estrategia inmunoterapia intratumoral consitente en la combinacion de BO-112 STING
euro 126,500.00
-
CANCER ORGANOIDS COCULTURED WITH T CELLS AND FIBROBLASTS AS A NEW TOOL TO TEST AND
BENCHMARK IMMUNOTHERAPY STRATEGIES
euro 79,983.00
2020
-
Estudio traslacional EC MONEO
euro 151,000.00
-
MINCITH. Metabolic requirements for immune INfiltration in effective Cancer ImmunoTHerapy.
euro 124,768.00
2019
-
Synergy of antibodies exerting ADCC and Monalizumab
euro 108,471.00